Nucala 100 MG in 1 mL Prefilled Syringe
- RxCUI
- 2173822
- RxNorm name
- Nucala 100 MG in 1 mL Prefilled Syringe
- Display name
- Nucala 100 MG in 1 mL Prefilled Syringe
- Full name
- Nucala 100 MG in 1 mL Prefilled Syringe
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:30
Purple Book Biologic Products#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nucala | MEPOLIZUMAB | GlaxoSmithKline LLC | fefb887c-e4ac-431e-8893-e9d1a5a63fea | 2025-08-06 | Warnings, Adverse reactions | 2173822 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| fefb887c-e4ac-431e-8893-e9d1a5a63fea | Nucala 100 MG in 1 mL Prefilled Syringe [PSN] · 1 ML mepolizumab 100 MG/ML Prefilled Syringe [Nucala] [SBD] · 1 ML Nucala 100 MG/ML Prefilled Syringe [SY] · Nucala 100 MG per 1 ML Prefilled Syringe [SY] | 4 | 24 | These highlights do not include all the information needed to use NUCALA safely and effectively. See full prescribing information for NUCALA. NUCALA (mepolizumab) for injection, for subcutaneous use NUCALA (mepolizumab) injection, for subcutaneous use Initial U.S. Approval: 2015 | 20250806 |